Zurueck zur Suche

Reporte zur Charge U7205AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

89Reporte angezeigt
1Todesfaelle
2Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
OK 21 ID 11 WA 7 KY 6 NM 3 TX 3 ME 3 CO 3 KS 3 UT 3 IN 2 DE 2

VAERS 2468225

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

kritisch
Staat
TN
Alter
0,6
Geschlecht
M
Eingang
04.10.2022
Impfdatum
26.09.2022
Beginn
29.09.2022
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / LL
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Baby was found dead of unknown cause on 9/29/22 at 8:30 am. Child sent for autopsy.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
pending
Aktuelle Erkrankungen
none
Vorgeschichte
Born at 26 weeks by SVD in a home toilet. In the NICU for 4 months. On vent for 1 mo and on oxygen for 2.5 mo. Large grade 4 IVH on left and grade 1 on right on DOL #1. EEG with cerebral dysfunction on DOL #2. Hemorrhagic hydrocephalus and VP shunt placed at 2 mo age. Retinopathy of prematurity. At 3 mo life, abnormal EEG and started Keppra. Pt was having no clinical seizures for approx 2 months prior to shots.
Andere Medikamente
Keppra
Allergien
None
Vorherige Impfungen
-

VAERS 2528399

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

schwer
Staat
WA
Alter
0,5
Geschlecht
M
Eingang
10.12.2022
Impfdatum
08.12.2022
Beginn
08.12.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Fatigue Pyrexia Respiratory viral panel Seizure Skin warm

Symptomtext

Vaccines administered in clinic around 9:15AM on 12/8/22 Parents first noted tactile fever at home around 1PM and gave tylenol Grandmother checked axillary temp at home at 5 PM and was noted to be 100.9, second dose of tylenol was given Mother returned from work after and he felt very hot to touch, so was taken to the local ER due to fever and he had a rectal temperature of 103.4 around 9PM. Received a dose of ibuprofen and within a few minutes began having seizure activity while in the ER and observed by ER staff/RNs. Seizure was brief, whole body. Had a period of fatigue after, but was able to awaken and take a bottle before discharge from the ER at 1AM on 12/9/22

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
12/8/22 - respiratory viral PCR panel entirely negative
Aktuelle Erkrankungen
None He did have a viral respiratory infection with cough/congestion about 40 days prior to vaccine Full RVP run at the time of the event and all negative
Vorgeschichte
None
Andere Medikamente
Acetaminophen
Allergien
None
Vorherige Impfungen
-

VAERS 2667704

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

moderat
Staat
WA
Alter
-
Geschlecht
F
Eingang
28.12.2023
Impfdatum
01.08.2023
Beginn
03.08.2023
Tage bis Beginn
2,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site swelling Injection site warmth Mobility decreased Pain

Symptomtext

Parent reported redness and swelling that grew quickly and wrapped around her left thigh; It was tender; Parent reported redness and swelling that grew quickly and wrapped around her left thigh; It was tender, hot to the touch; patient would not crawl; wailed in pain; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-OCT-2023 with the following VAERS Primary ID number 2667704-1. The original narrative from the sender is the following: "Parent reported redness and swelling that grew quickly and wrapped around her left thigh. It was tender, hot to the touch, patient would not crawl and "wailed in pain" Message was sent to the provider Dr. and they were advised to get seen in urgent care, support care suggested (ibuprofen)" The causal relationship between Vaxelis and the reported events "Parent reported redness and swelling that grew quickly and wrapped around her left thigh. It was tender, hot to the touch, patient would not crawl and "wailed in pain"" was assessed as Related. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Diaper rash; Otitis media acute
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2632505

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

mild
Staat
TX
Alter
-
Geschlecht
M
Eingang
28.09.2023
Impfdatum
10.05.2023
Beginn
10.05.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Diarrhoea Pyrexia Vomiting

Symptomtext

Started having diarrhea up to 7 episodes daily on 5/12 and has been ongoing since; Vomiting, multiple episodes started 7 hours after injection lasted 12 hours to put us at hour 19 after injection; Intermittent fever for first 48 hours, TMAX 102F; This spontaneous safety report, with reference number 2307USA002364 (VAERS ID 2632505-1), was received by the partner on 06-JUL-2023 and forwarded on 10-JUL-2023, from a health professional. Non-significant additional information was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID 2632505-1. The reporter did not provide an assessment of causal relationship between Vaxelis and the events "Started having diarrhea up to 7 episodes daily on 5/12 and has been ongoing since"," Vomiting, multiple episodes started 7 hours after injection lasted 12 hours to put us at hour 19 after injection " and " Intermittent fever for first 48 hours, TMAX 102F". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Fever
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2519196

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

mild
Staat
WA
Alter
-
Geschlecht
M
Eingang
04.04.2023
Impfdatum
10.11.2022
Beginn
20.11.2022
Tage bis Beginn
10,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Abdominal X-ray Barium enema Blood culture positive C-reactive protein Chest X-ray Full blood count Haematocrit Haemoglobin Intussusception Laboratory test Moraxella test positive Pallor Ultrasound abdomen abnormal Ultrasound abdomen Unresponsive to stimuli Urine analysis Vomiting X-ray abnormal

Symptomtext

Vomiting; Pallor; Unresponsive to stimuli; Found to have intussusception; Abdominal X-Ray; Barium enema; Blood culture positive; C-reactive protein; Chest X-ray; Full blood count; Hematocrit; Laboratory test; Moraxella test positive; Ultrasound abdomen; Urine analysis; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JAN-2023 with the following VAERS Primary ID 2519196-1. The original narrative from the sender is the following: Child has history of vomiting, pale appearance and unresponsiveness. Found to have intussusception and subsequent follow up for + blood culture of Moraxella. He was seen after this in ER and given ceftriaxone IM with repeat blood culture with ID consult. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events "Vomiting", "Pallor", "Unresponsive to stimuli", "Found to have intussusception", "Abdominal X-ray", "Barium enema", "Blood culture positive", "C-Reactive protein", "Chest X-Ray", "Full blood count", "Haematocrit", "Haemoglobin", "Laboratory Test", "Moraxella test positive", "Ultrasound abdomen", and "Urine analysis". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vomiting
Hospital-Tage
-
Labordaten
Test Name: Moraxella test positive
Aktuelle Erkrankungen
Pale; Unresponsive to stimuli; Vomiting
Vorgeschichte
-
Andere Medikamente
VITAMIN D3
Allergien
-
Vorherige Impfungen
-

VAERS 2544179

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

mild
Staat
VA
Alter
-
Geschlecht
F
Eingang
28.12.2022
Impfdatum
08.08.2022
Beginn
08.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Allergy test Urticaria

Symptomtext

Hives; Hives,benedryl resolved over 3-4days; This case was retrieved during the Reporting System monitoring on 12-OCT-2022 with the following Primary ID 2441061-1. The original narrative from the sender is the following: Referred for allergy testing before next vaccine, no results yet. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events " urticaria and allergy test" No further information is expected

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2533446

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

mild
Staat
ID
Alter
0,3
Geschlecht
M
Eingang
15.12.2022
Impfdatum
28.11.2022
Beginn
28.11.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Diarrhoea Irritability Rash Sleep disorder Wrong product administered

Symptomtext

Prevnar 20 was given to a 4-month-old instead of a Prevnar 13 for his second dose. Once error was caught, I contacted the CDC and manufacturing company for recommendations, reactions, and dosing. Mother of the patient was then contacted and informed of all information that was given, stated that the only reactions patient had were similar to any reaction of vaccines as well as a bit fussier, diarrhea and waking up more often at night. Mother then 1 week later reported that patient has had a rash around the mouth and chin and feeding issues.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None.
Vorgeschichte
None.
Andere Medikamente
None.
Allergien
None.
Vorherige Impfungen
-

VAERS 2441061

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

mild
Staat
VA
Alter
0,3
Geschlecht
F
Eingang
12.09.2022
Impfdatum
08.08.2022
Beginn
08.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Allergy test Urticaria

Symptomtext

HIVES , BENEDRYL; RESOLVED OVER 3-4 DAYS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
REFERRED FOR ALLERGY TESTING BEFORE NEXT VACCINE, NO RESULTS YET
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
-
Vorherige Impfungen
-

VAERS 2402883

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

mild
Staat
TX
Alter
0,2
Geschlecht
F
Eingang
05.08.2022
Impfdatum
04.08.2022
Beginn
05.08.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site induration Injection site inflammation Injection site nodule

Symptomtext

Per Mother the child woke up this morning 8/5 with an red knot and inflamed area in the thigh where the vaccine was given. The knot is extremely hard and inflamed. The child was examined by the Doctor and Mom was instructed on how to handle the inflammation and what to do if it worsened.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2182077

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

mild
Staat
MN
Alter
-
Geschlecht
M
Eingang
03.07.2022
Impfdatum
15.03.2022
Beginn
15.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Crying Erythema Peripheral swelling Injection site erythema Injection site swelling

Symptomtext

Large amount of redness going from the pts hip to his knee; Large amount of redness going from the pts hip to his knee along with swelling; Crying; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 11-APR-2022 with the following VAERS Primary ID 2182077-1. The original narrative from the sender is as below: "Large amount of redness going from the pts hip to his knee along with swelling, and inconsolable. Mom was advised to administer tylenol and gave a warm bath. ""Left leg""" History of Hydronephrosis.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
Medical History/Concurrent Conditions: Hydronephrosis
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2182077

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

mild
Staat
MN
Alter
-
Geschlecht
M
Eingang
03.07.2022
Impfdatum
15.03.2022
Beginn
15.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Crying Erythema Peripheral swelling Injection site erythema Injection site swelling

Symptomtext

Large amount of redness going from the pts hip to his knee; Large amount of redness going from the pts hip to his knee along with swelling; Crying; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 11-APR-2022 with the following VAERS Primary ID 2182077-1. The original narrative from the sender is as below: "Large amount of redness going from the pts hip to his knee along with swelling, and inconsolable. Mom was advised to administer tylenol and gave a warm bath. ""Left leg""" History of Hydronephrosis.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
Medical History/Concurrent Conditions: Hydronephrosis
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2727907

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
IA
Alter
-
Geschlecht
F
Eingang
28.12.2023
Impfdatum
03.11.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration Product administration error

Symptomtext

VAXELIS and IPOL at the same day and at the same time on a 2-month-old patient; This spontaneous non-serious safety report, with reference number 2023SA341553 (Inquiry# 01833332), was received by the partner on 06-NOV-2023 and forwarded on 07-NOV-2023, from a health professional. Due to the nature of the event, the causality between the events "VAXELIS and IPOL at the same day and at the same time on a 2-month-old patient" and Vaxelis was not applicable. Further information is expected. SIGNIFICANT FOLLOW-UP INFORMATION RECEIVED ON 10-NOV-2023, with reference number 2023SA341553 (Inquiry# 01836934), was received by the partner on 08-NOV-2023 and forwarded on 10-NOV-2023, from a health professional. The case is maintained as non-serious. Due to the nature of the event, the causality between the events "VAXELIS and IPOL at the same day and at the same time on a 2-month-old patient" and Vaxelis was not applicable. Further information is expected. Follow-up information was received on 28-NOV-2023, from a HCP. The case is maintained as non-serious. Due to the nature of the event, the causality between the events "VAXELIS and IPOL at the same day and at the same time on a 2-month-old patient" and Vaxelis was not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
ROTAVIRUS VACCINE; PNEUMOCOCCAL VACCINE
Allergien
-
Vorherige Impfungen
-

VAERS 2682525

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
WI
Alter
-
Geschlecht
M
Eingang
28.12.2023
Impfdatum
22.08.2023
Beginn
22.08.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age Wrong product administered

Symptomtext

We ONLY had the dark pink top Moderna 6month-5year vaccine at our center, which is what we gave; Lead and I later learned that we should have given a dark top, which lead was not even aware that that was an option and needed to be ordered.; This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-OCT-2023 with the following VAERS Primary ID 2682525-1. The original narrative from the sender is the following: Patient's mother requested to start the covid 10 series for patient. I spoke with and reviewed which vaccine to give with our lead pediatric nurse and covid 19 lead. We ONLY had the dark pink top Moderna 6month-5year vaccine at our center, which is what we gave. Lead and I later learned that we should have given a dark top, which lead was not even aware that that was an option and needed to be ordered. So we did not have the correct supply given to us. Due to the nature of the event, the causal relationship between Vaxelis and the reported events "We ONLY had the dark pink top Moderna 6month-5year vaccine at our center, which is what we gave" and "Lead and I later learned that we should have given a dark top, which lead was not even aware that that was an option and needed to be ordered" was not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2682525

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
WI
Alter
-
Geschlecht
M
Eingang
28.12.2023
Impfdatum
22.08.2023
Beginn
22.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age Wrong product administered

Symptomtext

We ONLY had the dark pink top Moderna 6month-5year vaccine at our center, which is what we gave; Lead and I later learned that we should have given a dark top, which lead was not even aware that that was an option and needed to be ordered.; This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-OCT-2023 with the following VAERS Primary ID 2682525-1. The original narrative from the sender is the following: Patient's mother requested to start the covid 10 series for patient. I spoke with and reviewed which vaccine to give with our lead pediatric nurse and covid 19 lead. We ONLY had the dark pink top Moderna 6month-5year vaccine at our center, which is what we gave. Lead and I later learned that we should have given a dark top, which lead was not even aware that that was an option and needed to be ordered. So we did not have the correct supply given to us. Due to the nature of the event, the causal relationship between Vaxelis and the reported events "We ONLY had the dark pink top Moderna 6month-5year vaccine at our center, which is what we gave" and "Lead and I later learned that we should have given a dark top, which lead was not even aware that that was an option and needed to be ordered" was not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2715674

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
IA
Alter
0,2
Geschlecht
F
Eingang
20.11.2023
Impfdatum
03.11.2023
Beginn
03.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

During our count of vaccines after clinic it was noted that the patient received both a vaxelis and polio vaccination. A call was placed to the parents to notify of the inadverent error of giving vaxelis and polio at the same time. The patient has not had any adverse reactions due to this event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2687493

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
-
Geschlecht
M
Eingang
27.09.2023
Impfdatum
24.08.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

VAXELIS was administered to a patient after experiencing a supported TE. HBP did not know the exact date of administration, between 8/18/2023 & 8/30/2023.No side effects reported.TE: 59.2 F,Time :7 hrs, 56 min,Previous TE:48.7F for 48 min,33.4F 10hrs; This spontaneous safety report, with reference number (Case ID #: 02462671) was received by the partner on 30-AUG-2023 and forwarded to company on 31-AUG-2023, from a Physician. This case was considered non-valid due to no patient identifiers (Temperature excursion only). Due to the nature of the event, the causality between the event "VAXELIS was administered to a patient after experiencing a supported TE. HBP did not know the exact date of administration, between 8/18/2023 & 8/30/2023.No side effects reported.TE: 59.2 F,Time :7 hrs, 56 min,Previous TE:48.7F for 48 min,33.4F 10hrs" and Vaxelis was not applicable. Significant Follow-up information was received by the partner on 14-SEP-2023 and forwarded to company on 14-SEP-2023, from a health care professional. This case is maintained as non-serious. Patient identifiers were received; therefore, the case is considered to be valid. Due to the nature of the event, the causality between the event "VAXELIS was administered to a patient after experiencing a supported TE. HBP did not know the exact date of administration, between 8/18/2023 & 8/30/2023.No side effects reported.TE: 59.2 F,Time :7 hrs, 56 min,Previous TE:48.7F for 48 min,33.4F 10hrs" and Vaxelis was not applicable. Further information is not expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2673809

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U7205AA

gering
Staat
CO
Alter
0,3
Geschlecht
M
Eingang
20.08.2023
Impfdatum
13.03.2023
Beginn
14.03.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dermatitis atopic

Symptomtext

SEVERE ATOPIC DERMATITIS RESULTED FROM THE VACCINES THE FOLLOWING DAYS AFTER THEY WERE GIVEN. THE CONDITION HAS LASTED EVER SINCE, FLARING UP AGAIN AND GETTING WORSE AFTER HIS 6 MONTH VACCINATIONS FROM THE SAME CARE FACILITY AND THE SAME VACCINES.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dermatitis atopic
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2650079

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
27.06.2023
Impfdatum
18.04.2023
Beginn
18.04.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

a 15 month old child presented for their third dose of VAXELIS. However, the child may have received 2 doses today; This non-serious spontaneous safety report with reference number 2023SA122541 (and inquiry number 01581087) was received by a partner on 18-APR-2023 and forwarded to agency on 19-APR-2023 from a HCP. Due to the nature of the event, the causality between Vaxelis and the reported event "a 15 month old child presented for their third dose of VAXELIS. However, the child may have received 2 doses today" was not applicable. Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2649647

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
UT
Alter
-
Geschlecht
M
Eingang
27.06.2023
Impfdatum
22.03.2023
Beginn
22.03.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

A medical assistant called and wants to know if there is any side effects because the both administered ACTHIB & Vaxelis to a patient. They concern was it both contains HIB; This non-serious spontaneous Safety Report was received by partner on 19-APR-2023 and forwarded to agency on 21-APR-2023 from other health professional. The reporter did not provide an assessment of the causal relationship between VAXELIS and the reported event "A medical assistant called and wants to know if there is any side effects because the both administered ACTHIB & Vaxelis to a patient. They concern was it both contains HIB". Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2649641

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
IN
Alter
-
Geschlecht
F
Eingang
27.06.2023
Impfdatum
28.02.2023
Beginn
28.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

Patient was given a Varivax in addition to a Pro Quad which contained Varicella; This case was retrieved during monitoring on 12-APR-2023 with the following Primary 2589271-1. The original narrative from the sender is as follows: Patient was given a Varivax in addition to a Pro Quad which contained Varicella. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event "Patient was given a Varivax in addition to a Pro Quad which contained Varicella". No further information is expected. Based on the available information, the events were not related to Vaxelis but to other vaccines. Vaxelis should have been considered a concomitant, however the case was retrieved and information was kept as reported in the form.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Asthma; Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2649640

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
NM
Alter
-
Geschlecht
F
Eingang
27.06.2023
Impfdatum
23.02.2023
Beginn
23.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

extra dose of hep b; Patient ordered Pentacel and received Vaxelis; extra dose of hep b; No adverse reaction noted; This case was retrieves during monitoring on 12-APR-2023 with the following Primary ID 2593261-1. The original narrative from the sender is as follows: Patient ordered Pentacel and received Vaxelis. No adverse reaction noted, just extra dose of hep b. Due to the nature of the events, the causal relationship between Vaxelis and the events "Patient ordered Pentacel and received Vaxelis. No adverse reaction noted, and extra dose of hep b" was not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2649638

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
ME
Alter
-
Geschlecht
F
Eingang
27.06.2023
Impfdatum
31.01.2023
Beginn
31.01.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

Patient was given multi dose that contained Hib as well as single antigen ACTHib causing a double dose of Hib; Patient was given multi dose that contained Hib as well as single antigen ACTHib causing a double dose of Hib; This non-serious case was received during monitoring on 12-APR-2023 with the following Primary ID 2573153-1. The original narrative from the sender is the following: Patient was given multi dose that contained Hib as well as single antigen ACTHib causing a double dose of Hib. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events "Patient was given multi dose that contained Hib as well as single antigen ACTHib causing a double dose of Hib". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2565932

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
AZ
Alter
-
Geschlecht
F
Eingang
27.06.2023
Impfdatum
07.12.2022
Beginn
07.12.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Wrong product administered

Symptomtext

Medication error. Combination Vaxelis was administered instead of the ordered DTaP, resulting in extraneous dose of Hep B, out of schedule IPV and duplicate HIB vaccine; Combination Vaxelis was administered instead of the ordered DTaP, duplicate HIB vaccine; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-APR-2023 with the following VAERS Primary ID 2565932-1. The original narrative from the sender is the following: Medication error. Combination Vaxelis was administered instead of the ordered DTaP, resulting in extraneous dose of Hep B, out of schedule IPV and duplicate HIB vaccine. No reactions noted at the time of service. No report from parent/guardian of adverse reaction. Parent was notified by provider. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events "Medication error. Combination Vaxelis was administered instead of the ordered DTaP, resulting in extraneous dose of Hep B, out of schedule IPV and duplicate HIB vaccine and Combination Vaxelis was administered instead of the ordered DTaP, duplicate HIB vaccine". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2565932

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
AZ
Alter
-
Geschlecht
F
Eingang
27.06.2023
Impfdatum
07.12.2022
Beginn
07.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Wrong product administered

Symptomtext

Medication error. Combination Vaxelis was administered instead of the ordered DTaP, resulting in extraneous dose of Hep B, out of schedule IPV and duplicate HIB vaccine; Combination Vaxelis was administered instead of the ordered DTaP, duplicate HIB vaccine; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-APR-2023 with the following VAERS Primary ID 2565932-1. The original narrative from the sender is the following: Medication error. Combination Vaxelis was administered instead of the ordered DTaP, resulting in extraneous dose of Hep B, out of schedule IPV and duplicate HIB vaccine. No reactions noted at the time of service. No report from parent/guardian of adverse reaction. Parent was notified by provider. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events "Medication error. Combination Vaxelis was administered instead of the ordered DTaP, resulting in extraneous dose of Hep B, out of schedule IPV and duplicate HIB vaccine and Combination Vaxelis was administered instead of the ordered DTaP, duplicate HIB vaccine". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2590836

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
DE
Alter
-
Geschlecht
F
Eingang
26.06.2023
Impfdatum
31.01.2023
Beginn
01.02.2023
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
C-reactive protein increased Coagulation test normal Computerised tomogram limb Peripheral swelling Ultrasound Doppler Ultrasound Doppler normal X-ray normal X-ray

Symptomtext

swelling of left leg specifically left calf noted by family shortly after vaccine was administered (Dad states next day and mom states about a week later). Seen in office for problem 2/17/23 and in ER 2/18/23; swelling of left leg specifically left calf noted by family shortly after vaccine was administered (Dad states next day and mom states about a week later). Seen in office for problem 2/17/23 and in ER 2/18/23; swelling of left leg specifically left calf noted by family shortly after vaccine was administered (Dad states next day and mom states about a week later). Seen in office for problem 2/17/23 and in ER 2/18/23; swelling of left leg specifically left calf noted by family shortly after vaccine was administered (Dad states next day and mom states about a week later). Seen in office for problem 2/17/23 and in ER 2/18/23; swelling of left leg specifically left calf noted by family shortly after vaccine was administered (Dad states next day and mom states about a week later). Seen in office for problem 2/17/23 and in ER 2/18/23; This case was retrieved during monitoring on 12-APR-2023 with the following Primary 2590836-1. The original narrative from the sender is as follows: swelling of left leg specifically left calf noted by family shortly after vaccine was administered (Dad states next day and mom states about a week later). Seen in office for problem 2/17/23 and in ER 2/18/23. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event "swelling of left leg specifically left calf noted by family shortly after vaccine was administered (Dad states next day and mom states about a week later). Seen in office for problem 2/17/23 and in ER 2/18/23". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
C-reactive protein increased
Hospital-Tage
-
Labordaten
Test Name: coagulation studies normal; Test Name: C--reactive protein increased; Test Name: Ultrasound doppler flow left leg; Test Name: X-RAY of tib/fib; Test Name: CT left leg
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2590836

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
DE
Alter
-
Geschlecht
F
Eingang
26.06.2023
Impfdatum
31.01.2023
Beginn
01.02.2023
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
C-reactive protein increased Coagulation test normal Computerised tomogram limb Peripheral swelling Ultrasound Doppler Ultrasound Doppler normal X-ray normal X-ray

Symptomtext

swelling of left leg specifically left calf noted by family shortly after vaccine was administered (Dad states next day and mom states about a week later). Seen in office for problem 2/17/23 and in ER 2/18/23; swelling of left leg specifically left calf noted by family shortly after vaccine was administered (Dad states next day and mom states about a week later). Seen in office for problem 2/17/23 and in ER 2/18/23; swelling of left leg specifically left calf noted by family shortly after vaccine was administered (Dad states next day and mom states about a week later). Seen in office for problem 2/17/23 and in ER 2/18/23; swelling of left leg specifically left calf noted by family shortly after vaccine was administered (Dad states next day and mom states about a week later). Seen in office for problem 2/17/23 and in ER 2/18/23; swelling of left leg specifically left calf noted by family shortly after vaccine was administered (Dad states next day and mom states about a week later). Seen in office for problem 2/17/23 and in ER 2/18/23; This case was retrieved during monitoring on 12-APR-2023 with the following Primary 2590836-1. The original narrative from the sender is as follows: swelling of left leg specifically left calf noted by family shortly after vaccine was administered (Dad states next day and mom states about a week later). Seen in office for problem 2/17/23 and in ER 2/18/23. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event "swelling of left leg specifically left calf noted by family shortly after vaccine was administered (Dad states next day and mom states about a week later). Seen in office for problem 2/17/23 and in ER 2/18/23". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
C-reactive protein increased
Hospital-Tage
-
Labordaten
Test Name: coagulation studies normal; Test Name: C--reactive protein increased; Test Name: Ultrasound doppler flow left leg; Test Name: X-RAY of tib/fib; Test Name: CT left leg
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2611189

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
ID
Alter
-
Geschlecht
M
Eingang
07.04.2023
Impfdatum
06.12.2022
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's; This spontaneous safety report, with reference number 02299086 (Interaction # 02299043) was received by the partner on 19-DEC-2022 and forwarded on 21-DEC-2022, from a health professional. Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis was not applicable. Further information is expected. For reference purposes, this case is linked to MCM-004406, MCM-004408, MCM-004409 and MCM-004410 (same reporter). SIGNIFICANT FOLLOW UP INFORMATION was received on 03-JAN-2023 from the health care professional. The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient. Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis remains not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis (Birth Weight 7lb (pounds) 11 oz (ounces))
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2608759

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
ID
Alter
-
Geschlecht
F
Eingang
04.04.2023
Impfdatum
06.12.2022
Beginn
01.12.2022
Tage bis Beginn
-
Dosis
3
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's; This spontaneous safety report, with reference number 02299086 (Interaction # 02299043) was received by the partner on 19-DEC-2022 and forwarded on 21-DEC-2022, from a health professional. Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis was not applicable. Further information is expected. For reference purposes, this case is linked to MCM-004406, MCM-004408, MCM-004409 and MCM-004407 (same reporter). SIGNIFICANT FOLLOW UP INFORMATION was received on 03-JAN-2023 from the health care professional. The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient. Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis remains not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2608758

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
ID
Alter
-
Geschlecht
M
Eingang
04.04.2023
Impfdatum
05.12.2022
Beginn
-
Tage bis Beginn
-
Dosis
3
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's; This spontaneous safety report, with reference number 02299086 (Interaction # 02299043) was received by the partner on 19-DEC-2022 and forwarded on 21-DEC-2022, from a health professional. Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis was not applicable. Further information is expected. For reference purposes, this case is linked to MCM-004406, MCM-004408, MCM-004407 and MCM-004410 (same reporter). SIGNIFICANT FOLLOW UP INFORMATION was received on 03-JAN-2023 from the health care professional. The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient. Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis remains not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis (Birth Weight: 7lb (pounds) 10z (ounces))
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2608757

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
ID
Alter
-
Geschlecht
F
Eingang
04.04.2023
Impfdatum
06.12.2022
Beginn
01.12.2022
Tage bis Beginn
-
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's; This spontaneous safety report, with reference number 02299086 (Interaction # 02299043) was received by the partner on 19-DEC-2022 and forwarded on 21-DEC-2022, from a health professional. Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis was not applicable. Further information is expected. For reference purposes, this case is linked to MCM-004406, MCM-004407, MCM-004409 and MCM-004410 (same reporter). SIGNIFICANT FOLLOW UP INFORMATION was received on 03-JAN-2023 from the health care professional. The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient. Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis remains not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis (Birth Weight: 6 lb (pounds) 14 oz (ounces))
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2608756

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
ID
Alter
-
Geschlecht
F
Eingang
04.04.2023
Impfdatum
05.12.2022
Beginn
01.12.2022
Tage bis Beginn
-
Dosis
3
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's; This spontaneous safety report, with reference number 02299086 (Interaction # 02299043) was received by the partner on 19-DEC-2022 and forwarded on 21-DEC-2022, from a health professional Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis was not applicable. Further information is expected. For reference purposes, this case is linked to MCM-004407, MCM-004408, MCM-004409 and MCM-004410 (same reporter). SIGNIFICANT FOLLOW UP INFORMATION was received on 03-JAN-2023 from the health care professional. The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient. Due to the nature of the event, the causality between the event "HCP calling to report a TE/ VAXELIS administered to patients since the temperature excursion happened. No additional AE's" and Vaxelis remains not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis (Birth Weight 6 pounds (lb) 4 oz (ounces))
Vorgeschichte
Medical History/Concurrent Conditions: Failure to thrive; GERD; Lactose intolerance; Plagiocephaly; Torticollis; Weight gain poor
Andere Medikamente
FAMOTIDINE
Allergien
-
Vorherige Impfungen
-

VAERS 2596341

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OR
Alter
0,2
Geschlecht
M
Eingang
14.03.2023
Impfdatum
01.03.2023
Beginn
02.03.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Disturbance in attention Drooling Feeling abnormal Hypotonia Infant irritability Posture abnormal Reduced facial expression Somnolence Unresponsive to stimuli

Symptomtext

Next day after his vaccines, he was dazed and not focusing well. Low muscle tone. Not holding head up as well. More fussy than usual. Drooling more. Less smiling than prior. Very sleepy. Possibly not opening eyes as far. Seems unresponsive at times. Follow up appointment with Dr on 3/9/23. Referral to neurology.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Disturbance in attention
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2593261

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
NM
Alter
0,3
Geschlecht
F
Eingang
08.03.2023
Impfdatum
23.02.2023
Beginn
23.02.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event Wrong product administered

Symptomtext

Patient ordered Pentacel and received Vaxelis. No adverse reaction noted, just extra dose of hep b.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2589271

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
IN
Alter
2,0
Geschlecht
F
Eingang
01.03.2023
Impfdatum
28.02.2023
Beginn
28.02.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

Patient was given a Varivax in addition to a Pro Quad which contained Varicella

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None known
Vorgeschichte
Asthma
Andere Medikamente
None known
Allergien
None known
Vorherige Impfungen
-

VAERS 2573153

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
ME
Alter
0,3
Geschlecht
F
Eingang
01.02.2023
Impfdatum
31.01.2023
Beginn
31.01.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

Patient was given multi dose that contained Hib as well as single antigen ACTHib causing a double dose of Hib

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2546450

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
WA
Alter
-
Geschlecht
U
Eingang
30.12.2022
Impfdatum
04.10.2022
Beginn
26.09.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Unspecified vaccines involved in an unspecified temperature excursion may have been administered to unknown patients/ the product reached a highest temperature of 9C; This non-serious spontaneous safety report, with reference number 02268180/ Interaction# 02268162 was received on 17-OCT-2022, from a non-health Professional. Due to the nature of the event, the causality between the event "Unspecified vaccines involved in an unspecified temperature excursion may have been administered to unknown patients/ the product reached a highest temperature of 9C" and Vaxelis was not applicable. Further information is expected. For reference purposes this case is linked to MCM-004173, MCM-004202 and MCM-004204.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544239

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
CO
Alter
-
Geschlecht
M
Eingang
28.12.2022
Impfdatum
24.10.2022
Beginn
24.10.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

Patient received Vaxelis and Engerix-B on the same date; This non-serious spontaneous safety report, with reference number 2022SA439355/ Inquiry# 01337995 was received by the partner on 25-OCT-2022 and forwarded on 27-OCT-2022 from another health professional. Due to the nature of the event, the causality between the event "Giving an extra dose of HEPTITIS B to a 6-month-old patient. The patient received several other vaccines the same day including VAXELIS." and Vaxelis was not applicable. Further information is expected. FOLLOW-UP INFORMATION was received by a partner on 28-OCT-2022 and forwarded on 02-NOV-2022, from a HCP. The case is maintained as non-serious. The HCP confirmed that no Adverse Events have been reported. Due to the nature of the event, the causality between the event "Patient received Vaxelis and Engerix-B on the same date" and Vaxelis remained not applicable. Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544233

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
WA
Alter
-
Geschlecht
U
Eingang
28.12.2022
Impfdatum
04.10.2022
Beginn
26.09.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

Unspecified vaccines involved in an unspecified temperature excursion may have been administered to unknown patients; This non-serious spontaneous safety report, with reference number 02268180/ Interaction# 02268162 was received on 17-OCT-2022, from a non-health Professional. Due to the nature of the event, the causality between the event "Unspecified vaccines involved in an unspecified temperature excursion may have been administered to unknown patients" and Vaxelis was not applicable. Further information is expected. For reference purposes this case is linked to MCM-004173, MCM-004202 and MCM-004203.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544232

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
WA
Alter
-
Geschlecht
U
Eingang
28.12.2022
Impfdatum
03.10.2022
Beginn
26.09.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Unspecified vaccines involved in an unspecified temperature excursion may have been administered to unknown patients/ the product reached a highest temperature of 9C; This non-serious spontaneous safety report, with reference number 02268180/ Interaction# 02268162 was received on 17-OCT-2022, from a non-health Professional. Due to the nature of the event, the causality between the event "Unspecified vaccines involved in an unspecified temperature excursion may have been administered to unknown patients/ the product reached a highest temperature of 9C" and Vaxelis was not applicable. Further information is expected. For reference purposes this case is linked to MCM-004173, MCM-004203 and MCM-004204.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544231

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
-
Geschlecht
M
Eingang
28.12.2022
Impfdatum
06.10.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This spontaneous safety report, with reference number 02244297, was received from a Health Professional on 17-OCT-2022. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. Notes: Source case MCM-004036, originally non-valid temperature excursion. With receipt of FUP information, 29 valid cases were created.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
ROTATEQ; PREVENAR 13
Allergien
-
Vorherige Impfungen
-

VAERS 2544230

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
-
Geschlecht
F
Eingang
28.12.2022
Impfdatum
06.10.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This spontaneous safety report, with reference number 02244297, was received from a Health Professional on 17-OCT-2022. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. Notes: Source case MCM-004036, originally non-valid temperature excursion. With receipt of FUP information, 29 valid cases were created.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544229

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
-
Geschlecht
F
Eingang
28.12.2022
Impfdatum
29.09.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This spontaneous safety report, with reference number 02244297, was received from a Health Professional on 17-OCT-2022. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. Notes: Source case MCM-004036, originally non-valid temperature excursion. With receipt of FUP information, 29 valid cases were created.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544228

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
-
Geschlecht
M
Eingang
28.12.2022
Impfdatum
29.09.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This spontaneous safety report, with reference number 02244297, was received from a Health Professional on 17-OCT-2022. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. Notes: Source case MCM-004036, originally non-valid temperature excursion. With receipt of FUP information, 29 valid cases were created.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544227

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
-
Geschlecht
F
Eingang
28.12.2022
Impfdatum
29.09.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This spontaneous safety report, with reference number 02244297, was received on 17-OCT-2022. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. Notes: Source case MCM-004036, originally non-valid temperature excursion. With receipt of FUP information, 29 valid cases were created.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544226

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
-
Geschlecht
M
Eingang
28.12.2022
Impfdatum
27.09.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This spontaneous safety report, with reference number 02244297, was received from a Health Professional on 17-OCT-2022. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. Notes: Source case MCM-004036, originally non-valid temperature excursion. With receipt of FUP information, 29 valid cases were created.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544225

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
-
Geschlecht
F
Eingang
28.12.2022
Impfdatum
04.10.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This spontaneous safety report, with reference number 02244297, was received from a Health Professional on 17-OCT-2022. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. Notes: Source case MCM-004036, originally non-valid temperature excursion. With receipt of FUP information, 29 valid cases were created.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544224

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
0,2
Geschlecht
F
Eingang
28.12.2022
Impfdatum
26.09.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This non-serious spontaneous safety report, with reference number 02244297, was received on 17-OCT-2022, from a Health Professional. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. For reference purposes this case is linked to MCM-004036, MCM-004174, MCM-004175, MCM-004176, MCM-004177, MCM-004178, MCM-004179, MCM-004180, MCM-004182, MCM-004181, MCM-004184, MCM-004185, MCM-004181, MCM-004187, MCM-004188, MCM-004189, MCM-004190, MCM-004191, MCM-004192, MCM-004193, MCM-004186, MCM-004195, MCM-004196, MCM-004197, MCM-004198, MCM-004199, MCM-004200, MCM-004201, due to same reporter and same event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544223

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
0,2
Geschlecht
M
Eingang
28.12.2022
Impfdatum
29.09.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This non-serious spontaneous safety report, with reference number 02244297, was received on 17-OCT-2022, from a Health Professional. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. For reference purposes this case is linked to MCM-004036, MCM-004174, MCM-004175, MCM-004176, MCM-004177, MCM-004178, MCM-004179, MCM-004180, MCM-004182, MCM-004181, MCM-004184, MCM-004185, MCM-004181, MCM-004187, MCM-004188, MCM-004189, MCM-004190, MCM-004191, MCM-004192, MCM-004186, MCM-004194, MCM-004195, MCM-004196, MCM-004197, MCM-004198, MCM-004199, MCM-004200, MCM-004201, due to same reporter and same event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544222

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
0,3
Geschlecht
F
Eingang
28.12.2022
Impfdatum
04.10.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This non-serious spontaneous safety report, with reference number 02244297, was received on 17-OCT-2022, from a Health Professional. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. For reference purposes this case is linked to MCM-004036, MCM-004174, MCM-004175, MCM-004176, MCM-004177, MCM-004178, MCM-004179, MCM-004180, MCM-004182, MCM-004181, MCM-004184, MCM-004185, MCM-004181, MCM-004187, MCM-004188, MCM-004189, MCM-004190, MCM-004191, MCM-004186, MCM-004193, MCM-004194, MCM-004195, MCM-004196, MCM-004197, MCM-004198, MCM-004199, MCM-004200, MCM-004201, due to same reporter and same event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544221

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
0,2
Geschlecht
F
Eingang
28.12.2022
Impfdatum
21.09.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This spontaneous safety report, with reference number 02244297, was received from a Health Professional on 17-OCT-2022. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. Notes: Source case MCM-004036, originally non-valid temperature excursion. With receipt of FUP information, 29 valid cases were created.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544220

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
0,3
Geschlecht
F
Eingang
28.12.2022
Impfdatum
03.10.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This spontaneous safety report, with reference number 02244297, was received from a Health Professional on 17-OCT-2022. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. Notes: Source case MCM-004036, originally non-valid temperature excursion. With receipt of FUP information, 29 valid cases were created.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544219

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
0,3
Geschlecht
F
Eingang
28.12.2022
Impfdatum
22.09.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This non-serious spontaneous safety report, with reference number 02244297, was received on 17-OCT-2022, from a Health Professional. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. For reference purposes this case is linked to MCM-004036, MCM-004174, MCM-004175, MCM-004176, MCM-004177, MCM-004178, MCM-004179, MCM-004180, MCM-004182, MCM-004181, MCM-004184, MCM-004185, MCM-004181, MCM-004187, MCM-004188, MCM-004186, MCM-004190, MCM-004191, MCM-004192, MCM-004193, MCM-004194, MCM-004195, MCM-004196, MCM-004197, MCM-004198, MCM-004199, MCM-004200, MCM-004201, due to same reporter and same event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544218

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
0,5
Geschlecht
F
Eingang
28.12.2022
Impfdatum
02.10.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This non-serious spontaneous safety report, with reference number 02244297, was received on 17-OCT-2022, from a Health Professional. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. For reference purposes this case is linked to MCM-004036, MCM-004174, MCM-004175, MCM-004176, MCM-004177, MCM-004178, MCM-004179, MCM-004180, MCM-004182, MCM-004181, MCM-004184, MCM-004185, MCM-004181, MCM-004187, MCM-004186, MCM-004189, MCM-004190, MCM-004191, MCM-004192, MCM-004193, MCM-004194, MCM-004195, MCM-004196, MCM-004197, MCM-004198, MCM-004199, MCM-004200, MCM-004201, due to same reporter and same event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544217

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
0,5
Geschlecht
M
Eingang
28.12.2022
Impfdatum
26.09.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This non-serious spontaneous safety report, with reference number 02244297, was received on 17-OCT-2022, from a Health Professional. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. For reference purposes this case is linked to MCM-004036, MCM-004174, MCM-004175, MCM-004176, MCM-004177, MCM-004178, MCM-004179, MCM-004180, MCM-004182, MCM-004181, MCM-004184, MCM-004185, MCM-004186, MCM-004183, MCM-004188, MCM-004189, MCM-004190, MCM-004191, MCM-004192, MCM-004193, MCM-004194, MCM-004195, MCM-004196, MCM-004197, MCM-004198, MCM-004199, MCM-004200, MCM-004201, due to same reporter and same event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544216

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
0,6
Geschlecht
F
Eingang
28.12.2022
Impfdatum
30.09.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This non-serious spontaneous safety report, with reference number 02244297, was received on 17-OCT-2022, from a Health Professional. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. For reference purposes this case is linked to MCM-004036, MCM-004174, MCM-004175, MCM-004176, MCM-004177, MCM-004178, MCM-004179, MCM-004180, MCM-004182, MCM-004181, MCM-004184, MCM-004185, MCM-004181, MCM-004187, MCM-004188, MCM-004189, MCM-004190, MCM-004191, MCM-004192, MCM-004193, MCM-004194, MCM-004195, MCM-004196, MCM-004197, MCM-004198, MCM-004199, MCM-004200, MCM-004201, due to same reporter and same event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544215

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
0,7
Geschlecht
M
Eingang
28.12.2022
Impfdatum
29.09.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This non-serious spontaneous safety report, with reference number 02244297, was received on 17-OCT-2022, from a Health Professional. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. For reference purposes this case is linked to MCM-004036, MCM-004174, MCM-004175, MCM-004176, MCM-004177, MCM-004178, MCM-004179, MCM-004180, MCM-004182, MCM-004181, MCM-004184, MCM-004183, MCM-004186, MCM-004187, MCM-004188, MCM-004189, MCM-004190, MCM-004191, MCM-004192, MCM-004193, MCM-004194, MCM-004195, MCM-004196, MCM-004197, MCM-004198, MCM-004199, MCM-004200, MCM-004201, due to same reporter and same event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544214

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
0,8
Geschlecht
M
Eingang
28.12.2022
Impfdatum
04.10.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This non-serious spontaneous safety report, with reference number 02244297, was received on 17-OCT-2022, from a Health Professional. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. For reference purposes this case is linked to MCM-004036, MCM-004174, MCM-004175, MCM-004176, MCM-004177, MCM-004178, MCM-004179, MCM-004180, MCM-004182, MCM-004181, MCM-004183, MCM-004185, MCM-004186, MCM-004187, MCM-004188, MCM-004189, MCM-004190, MCM-004191, MCM-004192, MCM-004193, MCM-004194, MCM-004195, MCM-004196, MCM-004197, MCM-004198, MCM-004199, MCM-004200, MCM-004201, due to same reporter and same event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544213

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
1,0
Geschlecht
F
Eingang
28.12.2022
Impfdatum
03.10.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This non-serious spontaneous safety report, with reference number 02244297, was received on 17-OCT-2022, from a Health Professional. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. For reference purposes this case is linked to MCM-004036, MCM-004174, MCM-004175, MCM-004176, MCM-004177, MCM-004178, MCM-004179, MCM-004180, MCM-004182, MCM-004181, MCM-004184, MCM-004185, MCM-004186, MCM-004187, MCM-004188, MCM-004189, MCM-004190, MCM-004191, MCM-004192, MCM-004193, MCM-004194, MCM-004195, MCM-004196, MCM-004197, MCM-004198, MCM-004199, MCM-004200, MCM-004201, due to same reporter and same event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544206

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
OK
Alter
0,3
Geschlecht
F
Eingang
28.12.2022
Impfdatum
25.08.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F; This spontaneous safety report, with reference number 02244297, was received from a Health Professional on 17-OCT-2022. Due to the nature of the event, the causality between the event "Multiple vaccines were administered following temperature excursions; to over 200 patients; lowest temperature was 33.1F" and Vaxelis was not applicable. No further information is expected. Notes: Source case MCM-004036, originally non-valid temperature excursion. With receipt of FUP information, 29 valid cases were created.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544203

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
WA
Alter
-
Geschlecht
U
Eingang
28.12.2022
Impfdatum
27.09.2022
Beginn
26.09.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Unspecified vaccines involved in an unspecified temperature excursion may have been administered to unknown patients; This non-serious spontaneous safety report, with reference number 02268180 / 02268162, was received by the partner on 14-OCT-2022 and forwarded on 17-OCT-2022, from a non-healthcare professional. Due to the nature of the event the causal relationship between Vaxelis and the event "unspecified vaccines involved in an unspecified temperature excursion may have been administered to unknown patients" was not applicable. Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544200

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
KY
Alter
-
Geschlecht
M
Eingang
28.12.2022
Impfdatum
15.09.2022
Beginn
15.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

ROTATEQ vaccine expired 09-04-2022; This case was retrieved during the Reporting System monitoring on 12-OCT-2022 with the following Primary ID 2464591-1. The original narrative from the sender is the following: ROTATEQ VACCINE EXPIRED 09-04-2022. The causal relationship between Vaxelis and the reported event "Expired Product Administered" is assessed as not applicable due to the nature of the event. No further information is expected. Note: Based on the available information, the event was not related to Vaxelis but to Rotateq vaccine. Vaxelis should have been considered a concomitant, however the case was retrieved from reporting system and information was kept as reported in the form.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544197

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
TX
Alter
-
Geschlecht
F
Eingang
28.12.2022
Impfdatum
04.08.2022
Beginn
05.08.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Vaccination site erythema Vaccination site induration Vaccination site inflammation Vaccination site nodule

Symptomtext

red knot and inflamed area in the thigh where the vaccine was given. The knot is extremely hard and inflamed.; red knot and inflamed area in the thigh where the vaccine was given. The knot is extremely hard and inflamed.; red knot and inflamed area in the thigh where the vaccine was given. The knot is extremely hard and inflamed.; red knot and inflamed area in the thigh where the vaccine was given; This non-serious case was received during the Reporting System monitoring on 12-OCT-2022 with the following Primary ID 2402883. The original narrative from the sender is as follows: Per mother the child woke up this morning 8/5 with an red knot and inflamed area in the thigh where the vaccine was given. The knot is extremely hard and inflamed. The child was examined by the Doctor and Mom was instructed on how to handle the inflammation and what to do if it worsened. The reporter did not assess the causal relationship between Vaxelis and "red knot and inflamed area in the thigh where the vaccine was given. The knot is extremely hard and inflamed." No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vaccination site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544190

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
MI
Alter
-
Geschlecht
F
Eingang
28.12.2022
Impfdatum
24.08.2022
Beginn
24.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

No known symptoms of adverse effect; Pt was given dose of Rotateq after the age of 8 months; This case was retrieve during the Reporting System monitoring on 12-OCT-2022 with the following Primary ID 2427502-1. The original narrative from the sender is the following: Pt was given dose of Rotateq after the age of 8 months, no known symptoms of adverse effect. Due to the nature of the events, the causal relationship between Vaxelis and "Pt was given dose of Rotateq after the age of 8 months" and "No known symptoms of adverse effect" was not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544183

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
KS
Alter
-
Geschlecht
F
Eingang
28.12.2022
Impfdatum
13.09.2022
Beginn
13.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired Product Administered; This case was retrieved during the Reporting System monitoring on 12-OCT-2022 with the following Primary ID 2464512-1. The original narrative from the sender is the following: Vaccine expired 09-04-2022. Due to the nature of events the causal relationship between Vaxelis and "Expired product administered" was not applicable. No further information is expected. Notes: Based on the available information, the expired vaccine administered is not sure if Vaxelis, however the case was retrieved from information was kept as reported in the form.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544177

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
KS
Alter
-
Geschlecht
M
Eingang
28.12.2022
Impfdatum
23.09.2022
Beginn
23.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event Vaccination error

Symptomtext

5-year-old child; Extra dose administered; Vaccination Error; No Adverse Event; This case was retrieved during the Reporting System monitoring on 12-OCT-2022 with the following Primary ID 2456155-1. The original narrative from the sender is the following: Patient presented with caregiver to school health clinic for vaccine update. Immunization record indicated child was due for DTaP, IPV, MMR, Varicella. Child received Vaxelis (DTaP, IPV, Hib, and Hep B), IPV, and ProQuad (MMR, varicella) at 0900 on 9/23/22. No signs or symptoms of local or systemic reaction immediately noted after immunization administration in office. Vaccine error was noted by provider at 1000. Medical director for school clinic was notified of event. Caregiver contacted by phone at 1053 and was notified with vaccine error, potential local/systemic reactions, instructed to monitor and report known adverse reactions, provider contact information, and plan to follow up by phone in 48 hours. No adverse reactions reported by caregiver at time of phone call. Due to the nature of events the causal relationship between Vaxelis and "Extra dose administered, Vaccination error, and No adverse event" was not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544168

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
CA
Alter
0,3
Geschlecht
F
Eingang
28.12.2022
Impfdatum
04.10.2022
Beginn
04.10.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration Laboratory test No adverse event

Symptomtext

they provided a patient with their 2nd dose of VAXELIS 26 days after the first dose instead of 28 days.; This non-serious spontaneous safety report, with reference number 2022SA410225 (and inquiry number 01308495), was received by a partner on 05-OCT-2022 and forwarded on 06-OCT-2022, from a health care professional. Due to the nature of the event the causal relationship between Vaxelis and "they provided a patient with their 2nd dose of VAXELIS 26 days after the first dose instead of 28 days." was not applicable. Further information is expected. SIGNIFICANT FOLLOW UP INFORMATION was received on 19-OCT-2022 from a health care professional. It was reported that there was no adverse reaction following vaccination. Due to the nature of the event the causal relationship between Vaxelis and "they provided a patient with their 2nd dose of VAXELIS 26 days after the first dose instead of 28 days." was not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
Test Date: 20221004; Test Name: Temp; Result Unstructured Data: 36.6; Test Date: 20221004; Test Name: HC; Result Unstructured Data: 41.7
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544166

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
UT
Alter
-
Geschlecht
U
Eingang
28.12.2022
Impfdatum
03.10.2022
Beginn
03.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

Received a dose of Vaxelis and a dose of Recombivax HB on the same day; This non-serious spontaneous safety report, with case number 02262554 (Interaction number 02262553), was received by a partner, on 06-OCT-2022 and forwarded on 06-OCT-2022 from an other health professional. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event "Received a dose of Vaxelis and a dose of Recombivax HB on the same day". Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544164

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
DC
Alter
5,0
Geschlecht
M
Eingang
28.12.2022
Impfdatum
28.09.2022
Beginn
28.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event

Symptomtext

A patient of 5 years old and 2 months received the vaccine VAXELIS; This non-serious spontaneous safety report, with reference number 2022SA404522, was received by the partner on 29-SEP-2022 and forwarded on 30-SEP-2022, from a physician. Due to the nature of the event the causal relationship between Vaxelis and the event "A patient of 5 years old and 2 months received the vaccine VAXELIS" was not applicable. Further information is expected. Non-significant follow-up information was received on 14-OCT-2022 from health care professional. Due to the nature of the event the causal relationship between Vaxelis and the event "A patient of 5 years old and 2 months received the vaccine VAXELIS" was not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2464571

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
KY
Alter
-
Geschlecht
F
Eingang
28.12.2022
Impfdatum
16.09.2022
Beginn
16.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

Rotateq vaccine expired 09-04-22; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-OCT-2022 with the following VAERS Primary ID 2464571-1. The original narrative from the sender is the following: Rotateq vaccine expired 09-04-22. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events "Rotateq vaccine expired 09-04-22". No further information is expected. Notes: Based on the available information, the events were not related to Vaxelis but to Rotateq vaccine. Vaxelis should have been considered a concomitant, however the case was retrieved from VAERS and information was kept as reported in the form.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2464571

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
KY
Alter
-
Geschlecht
F
Eingang
28.12.2022
Impfdatum
16.09.2022
Beginn
16.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

Rotateq vaccine expired 09-04-22; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-OCT-2022 with the following VAERS Primary ID 2464571-1. The original narrative from the sender is the following: Rotateq vaccine expired 09-04-22. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events "Rotateq vaccine expired 09-04-22". No further information is expected. Notes: Based on the available information, the events were not related to Vaxelis but to Rotateq vaccine. Vaxelis should have been considered a concomitant, however the case was retrieved from VAERS and information was kept as reported in the form.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2541288

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U7205AA

gering
Staat
ID
Alter
0,5
Geschlecht
F
Eingang
23.12.2022
Impfdatum
06.12.2022
Beginn
06.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AEs; temperature excursion; This spontaneous report was received from a registered nurse and refers to a 6-month-old female patient. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 06-DEC-2022, the patient was vaccinated with improperly stored doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, lot #1892790, expiration date: 03-DEC-2023, administered orally for prophylaxis (strength and dose were not provided); diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) injection, lot #U7205AA, expiration date: 23-OCT-2024, administered intramuscularly for prophylaxis (strength and dose were not provided); and pneumococcal vaccine conj (PCV 13) lot #FN5555, expiration date: 31-JUL-2024, administered intramuscularly (strength, dose, formulation, and indication were not provided) (product storage error). On an unknown date, before the administration, the vaccines underwent temperature excursion for unknown period of time. There was no adverse event reported. The reporter considered temperature excursion to be not related to suspect vaccines.; Sender's Comments: US-009507513-2212USA007828: US-009507513-2212USA007829: US-009507513-2212USA007830: US-009507513-2212USA007831: US-009507513-2212USA007832: US-009507513-2212USA007833: US-009507513-2212USA007834: US-009507513-2212USA007835: US-009507513-2212USA007836: US-009507513-2212USA007837: US-009507513-2212USA007838:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2541287

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U7205AA

gering
Staat
ID
Alter
0,5
Geschlecht
M
Eingang
23.12.2022
Impfdatum
05.12.2022
Beginn
05.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AEs; temperature excursion; This spontaneous report was received from a registered nurse and refers to a 6-month-old male patient. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 05-DEC-2022, the patient was vaccinated with improperly stored doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, lot #1892790, expiration date: 03-DEC-2023, administered orally for prophylaxis (strength and dose were not provided); diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) injection, lot #U7205AA, expiration date: 23-OCT-2024, administered intramuscularly for prophylaxis (strength and dose were not provided); and pneumococcal vaccine conj (PCV 13) lot #FN5555, expiration date: 31-JUL-2024, administered intramuscularly (strength, dose, formulation, and indication were not provided) (product storage error). On an unknown date, before the administration, the vaccines underwent temperature excursion for unknown period of time. There was no adverse event reported. The reporter considered temperature excursion to be not related to suspect vaccines.; Sender's Comments: US-009507513-2212USA007828: US-009507513-2212USA007829: US-009507513-2212USA007830: US-009507513-2212USA007831: US-009507513-2212USA007832: US-009507513-2212USA007833: US-009507513-2212USA007834: US-009507513-2212USA007835: US-009507513-2212USA007836: US-009507513-2212USA007837: US-009507513-2212USA007838:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2541286

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U7205AA

gering
Staat
ID
Alter
0,3
Geschlecht
F
Eingang
23.12.2022
Impfdatum
06.12.2022
Beginn
06.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age Product storage error

Symptomtext

No additional AEs; temperature excursion; Inappropriate age at vaccine administration; This spontaneous report was received from a registered nurse and refers to a 19 weeks old female patient. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 06-DEC-2022, the patient was vaccinated with improperly stored doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, lot #1892790, expiration date: 03-DEC-2023, administered orally for prophylaxis (strength and dose were not provided); diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) injection, lot #U7205AA, expiration date: 23-OCT-2024, administered intramuscularly for prophylaxis (strength and dose were not provided); and pneumococcal vaccine conj (PCV 13) lot #FN5555, expiration date: 31-JUL-2024, administered intramuscularly (strength, dose, formulation, and indication were not provided) (product storage error, product administered to patient of inappropriate age). On an unknown date, before the administration, the vaccines underwent temperature excursion for unknown period of time. There was no adverse event reported. The reporter considered temperature excursion to be not related to suspect vaccines.; Sender's Comments: US-009507513-2212USA007828:Same Reporter US-009507513-2212USA007829:Same Reporter US-009507513-2212USA007830:Same Reporter US-009507513-2212USA007831:Same Reporter US-009507513-2212USA007838:Same Reporter US-009507513-2212USA007833:Same Reporter US-009507513-2212USA007834:Same Reporter US-009507513-2212USA007835:Same Reporter US-009507513-2212USA007836:Same Reporter US-009507513-2212USA007837:Same Reporter

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2541285

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U7205AA

gering
Staat
ID
Alter
0,2
Geschlecht
M
Eingang
23.12.2022
Impfdatum
06.12.2022
Beginn
06.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AEs; temperature excursion; This spontaneous report was received from a registered nurse and refers to a 9 weeks old (also reported as 10 weeks) male patient. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 06-DEC-2022, the patient was vaccinated with improperly stored doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, lot #1892790, expiration date: 03-DEC-2023, administered orally for prophylaxis (strength and dose were not provided); diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) injection, lot #U7205AA, expiration date: 23-OCT-2024, administered intramuscularly for prophylaxis (strength and dose were not provided); and pneumococcal vaccine conj (PCV 13) lot #FN5555, expiration date: 31-JUL-2024, administered intramuscularly (strength, dose, formulation, and indication were not provided) (product storage error). On an unknown date, before the administration, the vaccines underwent temperature excursion for unknown period of time. There was no adverse event reported. The reporter considered temperature excursion to be not related to suspect vaccines.; Sender's Comments: US-009507513-2212USA007828: US-009507513-2212USA007829: US-009507513-2212USA007830: US-009507513-2212USA007838: US-009507513-2212USA007832: US-009507513-2212USA007833: US-009507513-2212USA007834: US-009507513-2212USA007835: US-009507513-2212USA007836: US-009507513-2212USA007837:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2541284

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U7205AA

gering
Staat
ID
Alter
0,5
Geschlecht
F
Eingang
23.12.2022
Impfdatum
05.12.2022
Beginn
05.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AEs; temperature excursion; This spontaneous report was received from a registered nurse and refers to a 6-month-old female patient. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 05-DEC-2022, the patient was vaccinated with improperly stored doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, lot #1892790, expiration date: 03-DEC-2023, administered orally for prophylaxis (strength and dose were not provided); diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) injection, lot #U7205AA, expiration date: 23-OCT-2024, administered intramuscularly for prophylaxis (strength and dose were not provided); and pneumococcal vaccine conj (PCV 13) lot #FN5555, expiration date: 31-JUL-2024, administered intramuscularly (strength, dose, formulation, and indication were not provided) (product storage error). On an unknown date, before the administration, the vaccines underwent temperature excursion for unknown period of time. There was no adverse event reported. The reporter considered temperature excursion to be not related to suspect vaccines.; Sender's Comments: US-009507513-2212USA007828: US-009507513-2212USA007829: US-009507513-2212USA007830: US-009507513-2212USA007831: US-009507513-2212USA007832: US-009507513-2212USA007833: US-009507513-2212USA007834: US-009507513-2212USA007835: US-009507513-2212USA007836: US-009507513-2212USA007837: US-009507513-2212USA007838:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2540280

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
ME
Alter
0,8
Geschlecht
F
Eingang
22.12.2022
Impfdatum
19.12.2022
Beginn
19.12.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

Double dose of HIB was given on 12/19/22 due to using Vaxelis Combo vaccine as well as ActHIB vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none disclosed
Vorgeschichte
none
Andere Medikamente
Nystatin topical 100,000 u/g ointment
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 2528822

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
NM
Alter
0,2
Geschlecht
M
Eingang
12.12.2022
Impfdatum
04.10.2022
Beginn
05.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Haematochezia

Symptomtext

had 1st rotavirus vaccine at 2 months of age and had blood in stool x 2 days: no further rotavirus vaccines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Haematochezia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2482384

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U7205AA

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
19.10.2022
Impfdatum
-
Beginn
04.10.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Healthcare business professional states unspecified vaccines involved in an unspecified temperature excursion may have been administered to unknown patients/ were administered to multiple patients since they were invloved in a temperature excursion; This spontaneous report was received from a health care professional referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/ allergies was not provided. On 04-OCT-2022, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, route of administration defaulted to oral, lot number: W020106, expiration date was internally confirmed as 16-MAY-2023 (exact dose and dose number were not reported) and an improperly stored dose of diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) pre-filled syringe, lot number: U7205AA, expiration date was internally confirmed as 23-OCT-2024 (exact dose, dose number, route of administration and anatomical location were not reported) for prophylaxis (product storage error). No additional adverse event (AE) details were provided (no adverse event). On 26-SEP-2022, the administered doses of the suspect vaccines experienced a temperature excursion of the highest temperature of 9 degrees Celsius (C) for a total time of 15 minutes. It was unknown, whether the administered suspect vaccines experienced a previous temperature excursion. It was unknown, whether a digital data logger was involved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2482383

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U7205AA

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
19.10.2022
Impfdatum
-
Beginn
04.10.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Healthcare business professional states unspecified vaccines involved in an unspecified temperature excursion may have been administered to unknown patients/ were administered to multiple patients since they were invloved in a temperature excursion; This spontaneous report was received from a health care professional referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/ allergies was not provided. On 04-OCT-2022, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, route of administration defaulted to oral, lot number: W020106, expiration date was internally confirmed as 16-MAY-2023 (exact dose and dose number were not reported) and an improperly stored dose of diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) pre-filled syringe, lot number: U7205AA, expiration date was internally confirmed as 23-OCT-2024 (exact dose, dose number, route of administration and anatomical location were not reported) for prophylaxis (product storage error). No additional adverse event (AE) details were provided (no adverse event). On 26-SEP-2022, the administered doses of the suspect vaccines experienced a temperature excursion of the highest temperature of 9 degrees Celsius (C) for a total time of 15 minutes. It was unknown, whether the administered suspect vaccines experienced a previous temperature excursion. It was unknown, whether a digital data logger was involved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2482382

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U7205AA

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
19.10.2022
Impfdatum
-
Beginn
03.10.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Healthcare business professional states unspecified vaccines involved in an unspecified temperature excursion may have been administered to unknown patients/ were administered to multiple patients since they were invloved in a temperature excursion; This spontaneous report was received from a health care professional referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/ allergies was not provided. On 03-OCT-2022, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, route of administration defaulted to oral, lot number: W020106, expiration date was internally confirmed as 16-MAY-2023 (exact dose and dose number were not reported) and an improperly stored dose of diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) pre-filled syringe, lot number: U7205AA, expiration date was internally confirmed as 23-OCT-2024 (exact dose, dose number, route of administration and anatomical location were not reported) for prophylaxis (product storage error). No additional adverse event (AE) details were provided (no adverse event). On 26-SEP-2022, the administered doses of the suspect vaccines experienced a temperature excursion of the highest temperature of 9 degrees Celsius (C) for a total time of 15 minutes. It was unknown, whether the administered suspect vaccines experienced a previous temperature excursion. It was unknown, whether a digital data logger was involved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2482380

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U7205AA

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
19.10.2022
Impfdatum
27.09.2022
Beginn
27.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Healthcare business professional states unspecified vaccines involved in an unspecified temperature excursion may have been administered to unknown patients.; This spontaneous report was received from a health care professional referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/ allergies was not provided. On 27-SEP-2022, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, administered orally, lot number: W020106, expiration date was internally confirmed as 16-MAY-2023 (dose and dose number were not reported) and an improperly stored dose of diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) pre-filled syringe, lot number: U7205AA, expiration date was internally confirmed as 23-OCT-2024 (dose, dose number, route of administration and anatomical location were not reported) for prophylaxis (product storage error). No additional adverse event (AE) details were provided (no adverse event). On 26-SEP-2022, the administered doses of the suspect vaccines experienced a temperature excursion of the highest temperature of 9 degrees Celsius (C) for a total time of 15 minutes. It was unknown, whether the administered suspect vaccines experienced a previous temperature excursion. It was unknown, whether a digital data logger was involved.; Sender's Comments: US-009507513-2210USA006289:2210USA006289 US-009507513-2210USA006287:2210USA006287 US-009507513-2210USA006288:2210USA006288

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2464530

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
KY
Alter
-
Geschlecht
U
Eingang
18.10.2022
Impfdatum
06.09.2022
Beginn
06.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event Unevaluable event

Symptomtext

No additional AE reported.; an expired dose of ROTATEQ was administered to the patient on 6SEP2022; This spontaneous report was received from a registered nurse (R.N.), concerning a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies, concurrent conditions and concomitant medications were unknown. On 06-SEP-2022, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, at a dose of 2 milliliter, lot #1741381, expiration date 04-SEP-2022, administered orally for prophylaxis (expired product administered). The patient did not experience any adverse event. The reporter stated that the vaccine had not been involved in a temperature excursion through the date of administration. No additional information provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2464591

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
KY
Alter
-
Geschlecht
U
Eingang
15.10.2022
Impfdatum
15.09.2022
Beginn
15.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

Caller is a nurse reporting that an expired dose of ROTATEQ was administered to the patient on 15SEP2022. Caller confirmed that the ROTATEQ has not been involved in a temperautre excursion through the date of administration. No additional information; No additional AE; Information has been received from a nurse, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 15-SEP-2022, the patient was vaccinated with an expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 2 ml, lot #1741381, expiration date: 04-SEP-2022, administered orally for prophylaxis (strength was not provided). The reporting nurse stated that the rotavirus vaccine, live, oral, pentavalent (ROTATEQ) has not been involved in a temperature excursion through the date of administration. No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2474330

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U7205AA

gering
Staat
UT
Alter
0,2
Geschlecht
U
Eingang
11.10.2022
Impfdatum
03.10.2022
Beginn
03.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Overdose

Symptomtext

No additional AE details were provided.; the patient is a 2 month old infant who received a dose of VAXELIS and a dose of RECOMBIVAX HB on the same day on 3OCT2022.; This spontaneous report has been received from a medical assistant concerning to a 2-month-old infant patient of an unknown gender. The patient's medical history, concurrent conditions, previous drug reactions or allergies, and concomitant therapies were not provided. On 03-OCT-2022, the patient received a dose of hepatitis b vaccine (recombinant) (thimerosal free) (RECOMBIVAX HB) intramuscular injection, at a dose of 0.5 milliliter (ml) (strength, vaccination scheme frequency, route of administration, and anatomical site of application were not provided; lot number T032918 that was verified to be valid for vial formulation with an expiration date reported and established as 12-NOV-2022) as prophylaxis; and on the same date, received a dose of diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) injection, at a dose of 0.5 ml (strength, vaccination scheme frequency, route of administration, indication and anatomical site of application were not provided; lot number U7205AA that was verified to be valid with an expiration date reported as 24-OCT-2023 but upon internal validation established as 23-OCT-2024) (overdose). By the reporting time, the patient did not have any adverse reactions. There was no additional adverse event (AE) reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2464512

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
KY
Alter
-
Geschlecht
U
Eingang
06.10.2022
Impfdatum
13.09.2022
Beginn
13.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; Caller is a nurse reporting that an expired dose of ROTATEQ was administered to the patient on 13SEP2022. Caller confirmed that the ROTATEQ has not been involved in a temperautre excursion through the date of administration. No additional information; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. No information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions or allergies was provided. On 13-SEP-2022, the patient was vaccinated with an expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (expired product administered) 2 ml, orally, lot # 1741381 with expiration date of 04-SEP-2022, for prophylaxis. It was confirmed that the vaccine did not have a previous temperature excursion. No additional event reporter, no further information provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2464357

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
CO
Alter
0,8
Geschlecht
F
Eingang
28.09.2022
Impfdatum
20.09.2022
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Unevaluable event

Symptomtext

None

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
-
Allergien
N.K.D.A
Vorherige Impfungen
-

VAERS 2456155

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
KS
Alter
5,0
Geschlecht
M
Eingang
23.09.2022
Impfdatum
23.09.2022
Beginn
23.09.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event Vaccination error

Symptomtext

Patient presented with caregiver to school health clinic for vaccine update. Immunization record indicated child was due for DTaP, IPV, MMR, Varicella. Child received Vaxelis (DTaP, IPV, Hib, and Hep B), IPV, and ProQuad (MMR, varicella) at 0900 on 9/23/22. No signs or symptoms of local or systemic reaction immediately noted after immunization administration in office. Vaccine error was noted by provider at 1000. Medical director for school clinic was notified of event. Caregiver contacted by phone at 1053 and was notified with vaccine error, potential local/systemic reactions, instructed to monitor and report known adverse reactions, provider contact information, and plan to follow up by phone in 48 hours. No adverse reactions reported by caregiver at time of phone call.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None at the time of the vaccination, no known illness to provider up to month prior
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2431284

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
MA
Alter
0,3
Geschlecht
M
Eingang
07.09.2022
Impfdatum
31.08.2022
Beginn
02.09.2022
Tage bis Beginn
2,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Barium double contrast Intestinal obstruction Intussusception Ultrasound scan abnormal Urinary system X-ray

Symptomtext

Intussusception dx at Hospital ED. Air enema x3 to correct on 09/03/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Barium double contrast
Hospital-Tage
1,0
Labordaten
KUB showed obstruction. Ultrasound then done that showed intussusception.
Aktuelle Erkrankungen
Covid-19 positive on 07/27/2022. Cough and fever with covid
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 2427502

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7205AA

gering
Staat
MI
Alter
1,0
Geschlecht
F
Eingang
02.09.2022
Impfdatum
24.08.2022
Beginn
24.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

Pt was given dose of Rotateq after the age of 8 months, no known symptoms of adverse effect

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
-
Andere Medikamente
unknown
Allergien
NKDA
Vorherige Impfungen
-